Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 08-2017 | 08-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,409 | 135 | 0 | N/A | N/A |
| Accounts receivable | -826 | -488 | -218 | 0 | 2 |
| Accounts payable and accrued liabilities | N/A | 318 | 791 | -2 | -9 |
| Other Working Capital | -1,408 | -242 | 305 | -2 | 2 |
| Other Operating Activity | -14,128 | -13,298 | -998 | -18 | -23 |
| Operating Cash Flow | $-13,954 | $-13,575 | $-119 | $-21 | $-27 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -409 | -2,961 | -6,086 | N/A | N/A |
| Net Acquisitions | 2 | 1,499 | 0 | N/A | N/A |
| Purchase Of Investment | 0 | -5,874 | 0 | N/A | N/A |
| Sale Of Investment | 470 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -298 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-235 | $-7,336 | $-6,086 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 28 | 14 |
| Debt Repayment | -43 | N/A | N/A | 0 | -14 |
| Common Stock Issued | 3,517 | 33,030 | 10,962 | N/A | N/A |
| Other Financing Activity | 609 | -82 | -1,012 | 0 | 34 |
| Financing Cash Flow | $4,082 | $32,948 | $9,951 | $28 | $34 |
| Beginning Cash Position | 16,180 | 3,480 | 24 | 7 | 0 |
| End Cash Position | 6,073 | 15,517 | 3,769 | 14 | 7 |
| Net Cash Flow | $-10,107 | $12,037 | $3,745 | $7 | $7 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,954 | -13,575 | -119 | -21 | -27 |
| Capital Expenditure | -707 | -2,961 | -6,086 | N/A | N/A |
| Free Cash Flow | -14,661 | -16,536 | -6,205 | -21 | -27 |